CAS 2387704-62-1

1-Benzoyl-4-oxo-nipecotic acid methyl ester

CAS: 2387704-62-1

Fórmula: C₂₁H₂₀Cl₂N₁₀O

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 499.3559

Ref: IN-DA01KGHT

N-((5,6-Dichloro-1H-Benzo[D]Imidazol-2-Yl)Methyl)-9-(1-Methyl-1H-Pyrazol-4-Yl)-2-Morpholino-9H-Purin-6-Amine

CAS: 2387704-62-1

N-((5,6-Dichloro-1H-Benzo[D]Imidazol-2-Yl)Methyl)-9-(1-Methyl-1H-Pyrazol-4-Yl)-2-Morpholino-9H-Purin-6-Amine

Pureza: 98%

Peso molecular: 499.36g/mol

Ref: 54-OR1023200

SR-4835

CAS: 2387704-62-1

SR-4835

Pureza: ≥98%

Peso molecular: 499.36g/mol

Ref: 54-BUP12608

SR-4835

CAS: 2387704-62-1

SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4.9 nM), which disables triple-negative breast cancer (

Fórmula: C₂₁H₂₀Cl₂N₁₀O

Pureza: 98.09% - >99.99%

Cor e Forma: Solid

Peso molecular: 499.36

Ref: TM-T8325

SR 4835

CAS: 2387704-62-1

SR 4835 is a synthetic compound, which is an advanced molecular entity derived from extensive medicinal chemistry efforts. This compound exhibits a novel mechanism of action, targeting specific cellular pathways implicated in disease processes. SR 4835 functions by modulating enzyme activity, thus influencing intracellular signaling cascades that play a critical role in pathophysiological conditions.

Fórmula: C₂₁H₂₀Cl₂N₁₀O

Pureza: Min. 98 Area-%

Cor e Forma: Powder

Peso molecular: 499.36 g/mol

Ref: 3D-BS180614

SR-4835

CAS: 2387704-62-1

Pureza: 98%

Peso molecular: 498.12

Ref: 10-F840928